Ziprasidone Pharmacokinetics Using a Reduced Food Effect Formulation Compared to Pharmacokinetics From Commercial Capsules
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
Commercial ziprasidone capsules show a large increase in bioavailability with food. The
formulation tested in this study aims to reduce or eliminate that increase.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.